137 related articles for article (PubMed ID: 9825655)
1. [Von Willebrand factor in plasma of patients with rheumatoid arthritis and lupus erythematosus].
Paczuski R; Iwan-Zietek I; Kotschy M; Bielawska J; Sadkiewicz S
Pol Merkur Lekarski; 1998 May; 4(23):254-6. PubMed ID: 9825655
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor in the plasma of patients with rheumatic diseases.
Duţu A; Rus V; Boloşiu HD; Parasca I; Cristea A; Malide D
Med Interne; 1989; 27(4):273-8. PubMed ID: 2617082
[TBL] [Abstract][Full Text] [Related]
3. [Studies on von Willebrand factor antigen in endothelial cells and sera of patients with connective tissue diseases].
Kida S
Ryumachi; 1990 Feb; 30(1):17-25. PubMed ID: 1696033
[TBL] [Abstract][Full Text] [Related]
4. [Effect of severe multiple trauma complicated by acute lung injury on endothelial cell activity].
Siemiatkowski A; Kłoczko J; Wereszczyńska-Siemiatkowska U; Czaban SL
Przegl Lek; 2001; 58(7-8):767-71. PubMed ID: 11769384
[TBL] [Abstract][Full Text] [Related]
5. Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus.
Ferro D; Basili S; Roccaforte S; Di Franco M; Cipollone F; Ciabattoni G; Davì G
Arthritis Rheum; 1999 Dec; 42(12):2689-97. PubMed ID: 10616019
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor antigen levels in Behçet disease.
Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
[TBL] [Abstract][Full Text] [Related]
7. [The level of serum thymic activity in patients with rheumatoid arthritis and systemic lupus erythematosus].
Ternovoĭ KS; Selezneva TN; Gandzha IM; Babynina LIa; Skorik AIu; Ermekova VM
Ter Arkh; 1993; 65(8):66-7. PubMed ID: 8211807
[TBL] [Abstract][Full Text] [Related]
8. Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus.
Viallard JF; Pellegrin JL; Vergnes C; Borel-Derlon A; Clofent-Sanchez G; Nurden AT; Leng B; Nurden P
Br J Haematol; 1999 May; 105(2):532-7. PubMed ID: 10233433
[TBL] [Abstract][Full Text] [Related]
9. [Thrombomodulin, von Willebrand factor and tissue plasminogen activator in the blood plasma of obese women and men].
Rość D; Drewniak W; Kinasz-Rózycka I; Kulwas A; Michalski A
Pol Merkur Lekarski; 2003 Dec; 15(90):518-20. PubMed ID: 15058251
[TBL] [Abstract][Full Text] [Related]
10. [Von Willebrand factor in plasma of patients with age related macular degeneration].
Malukiewicz-Wiśniewska G; Rość D; Kałuzny B; Kałuzny JJ
Klin Oczna; 2005; 107(1-3):70-2. PubMed ID: 16052806
[TBL] [Abstract][Full Text] [Related]
11. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
Bronisz M; Rość D; Paczuski R; Nartowicz E; Bronisz A
Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
13. Von Willebrand factor (vWF) antigen levels and function in healthy Thais.
Rojnuckarin P; Akkawat B; Intragumtornchai T
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1292-7. PubMed ID: 16438160
[TBL] [Abstract][Full Text] [Related]
14. [Laboratory indicators of endothelial involvement in rheumatic diseases associated with vasculitis in children].
Dolezalová P; Telekesová P; Nĕmcová D; Bĕlorová J; Kvasnicka J; Hoza J
Cas Lek Cesk; 2003; 142(10):615-9. PubMed ID: 14635427
[TBL] [Abstract][Full Text] [Related]
15. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
16. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
17. [The von Willebrand factor antigen in patients with rheumatoid arthritis: a method for its determination and the clinical significance].
Baranov AA; Nasonov EL; Shilkina NP; Samoriadova OG; Balabanova RM; Bimbazhapov RS
Ter Arkh; 1993; 65(4):69-72. PubMed ID: 8059412
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M; Kim D; Oh M; Jeong H; Choi I
Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
[TBL] [Abstract][Full Text] [Related]
19. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
[TBL] [Abstract][Full Text] [Related]
20. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
Tam LS; Fan B; Li EK; Thomas GN; Yim SF; Haines CJ; Tomlinson B
J Rheumatol; 2003 Jul; 30(7):1479-84. PubMed ID: 12858444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
